scorecardresearch
Sunday, Nov 27, 2022

Zydus gets restricted nod for use of Hepatitis drug

Originally approved for Hepatitis C, the “multicentric trial” of the drug —conducted in 20-25 centers across India — has shown lesser need for supplemental oxygen.

A single dose of Virafin shows significant improvement. 91.15% of patients were RT PCR negative by day 7, Zydus Cadila claims. (Express photo/Representational)

Zydus Cadila on Friday announced that the Drug Controller General of India (DCGI) has given “Restricted Emergency Use Approval” for the use of Virafin, Pegylated Interferon alpha-2b (PegIFN), to treat moderate Covid-19 infection in adults.

Originally approved for Hepatitis C, the “multicentric trial” of the drug —conducted in 20-25 centers across India — has shown lesser need for supplemental oxygen.

This “clearly indicates that it was able to control respiratory distress and failure which has been one of the major challenges in treating Covid-19,” the company stated in a filing to the BSE on Friday. The company had sought approval from DGCI earlier this month.

A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered during the early stage of infection, Virafin will help patients recover faster and avoid much of the complications. Virafin will be available on the prescription of medical specialist for use in hospital/institutional setup, it added.

Subscriber Only Stories
NIA to Home Ministry: Break nexus, move gangsters from north to jails in ...Premium
37 Muslim Independents in two Surat seats: Garment worker to domestic hel...Premium
Sunroofs to air purifiers, auto majors target an emerging segment: 30-minusPremium
When the water trains came to parched RajkotPremium

Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited stated, “The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management.”

Zydus is also working on a Covid vaccine ZyCoV-D.

First published on: 23-04-2021 at 06:27:32 pm
Next Story

Karnataka needs 1,471 tonnes of oxygen daily, 2 lakh Remdevisir doses in 10 days: Yediyurappa tells PM Modi

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement
close